Quality of clinical management of cardiometabolic risk factors in patients with severe mental illness in a specialist mental health care setting

References

• Rossler W, Salize HJ, Van Os J, et al. Size of burden of schizophrenia and psychotic disorders. Eur Neuropsychopharmacol. 2005;15(4):399–409.
   PubMed Web of Science ®Google Scholar
• Birkenaes AB, Opjordsmoen S, Brunborg C, et al. The level of cardiovascular risk factors in bipolar disorder equals that of schizophrenia: a comparative study. J Clin Psychiatry. 2007;68(06):917–923.
   PubMedGoogle Scholar
• Correll CU, Solmi M, Veronese N, et al. Prevalence, incidence and mortality from cardiovascular disease in patients with pooled and specific severe mental illness: a large-scale meta-analysis of 3,211,768 patients and 113,383,368 controls. World Psychiatry. 2017;16(2):163–180.
   PubMed Web of Science ®Google Scholar
• Kaur J. A comprehensive review on metabolic syndrome. Cardiol Res Pract. 2014;2014:1–62.
   Google Scholar
• Mitchell AJ, Vancampfort D, Sweers K, et al. Prevalence of metabolic syndrome and metabolic abnormalities in schizophrenia and related disorders–a systematic review and meta-analysis. SchizophrBull. 2011;39(2):306-18.
   PubMedGoogle Scholar
• Andersen E, Holmen TL, Egeland J, et al. Physical activity pattern and cardiorespiratory fitness in individuals with schizophrenia compared with a population-based sample. Schizophr Res. 2018;201:98–104.
   PubMed Web of Science ®Google Scholar
• Vancampfort D, Probst M, Knapen J, et al. Associations between sedentary behaviour and metabolic parameters in patients with schizophrenia. Psychiatry Res. 2012;200(2-3):73–78.
   PubMed Web of Science ®Google Scholar
• Firth J, Stubbs B, Teasdale SB, et al. Diet as a hot topic in psychiatry: a population-scale study of nutritional intake and inflammatory potential in severe mental illness. World Psychiatry. 2018;17(3):365–367.
   PubMed Web of Science ®Google Scholar
• Janney CA, Ganguli R, Richardson CR, et al. Sedentary behavior and psychiatric symptoms in overweight and obese adults with schizophrenia and schizoaffective disorders (WAIST study). Schizophr Res. 2013;145(1-3):63–68.
   PubMed Web of Science ®Google Scholar
• Sarris J, Logan AC, Akbaraly TN, et al. International Society for Nutritional Psychiatry Research. Nutritional medicine as mainstream in psychiatry. Lancet Psychiatry. 2015;2(3):271–274.
   PubMed Web of Science ®Google Scholar
• Plana-Ripoll O, Pedersen CB, Agerbo E, et al. A comprehensive analysis of mortality-related health metrics associated with mental disorders: a nationwide, register-based cohort study. Lancet. 2019;394(10211):1827–1835.
   PubMed Web of Science ®Google Scholar
• Saha S, Chant D, McGrath J. A systematic review of mortality in schizophrenia: is the differential mortality gap worsening over time? Arch Gen Psychiatry. 2007;64(10):1123–1131.
   PubMed Web of Science ®Google Scholar
• Crump C, Sundquist K, Winkleby MA, et al. Comorbidities and mortality in bipolar disorder: a swedish national cohort study. JAMA Psychiatry. 2013;70(9):931–939.
   PubMed Web of Science ®Google Scholar
• Rødevand L, Steen NE, Elvsåshagen T, et al. Cardiovascular risk remains high in schizophrenia with modest improvements in bipolar disorder during past decade. Acta Psychiatr Scand. 2019;139(4):348–360.
   PubMed Web of Science ®Google Scholar
• Allison DB, Newcomer JW, Dunn AL, et al. Obesity among those with mental disorders: a national institute of mental health meeting report. Am J Prev Med. 2009;36(4):341–350.
   PubMed Web of Science ®Google Scholar
• Newcomer JW. Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review. CNS Drugs. 2005;19(Suppl 1):1–93.
   PubMed Web of Science ®Google Scholar
• Tenback D, Pijl B, Smeets H, et al. All-cause mortality and medication risk factors in schizophrenia: a prospective cohort study. J Clin Psychopharmacol. 2012;32(1):31–35.
   PubMed Web of Science ®Google Scholar
• Torniainen M, Mittendorfer-Rutz E, Tanskanen A, et al. Antipsychotic treatment and mortality in schizophrenia. Schizophr Bull. 2015;41(3):656–663.
   PubMed Web of Science ®Google Scholar
• Vermeulen J, van Rooijen G, Doedens P, et al. Antipsychotic medication and long-term mortality risk in patients with schizophrenia; a systematic review and meta-analysis. Psychol Med. 2017;47(13):2217–2228.
   PubMed Web of Science ®Google Scholar
• Henderson DC, Vincenzi B, Andrea NV, et al. Pathophysiological mechanisms of increased cardiometabolic risk in people with schizophrenia and other severe mental illnesses. Lancet Psychiatry. 2015;2(5):452–464.
   PubMed Web of Science ®Google Scholar
• Solmi M, Murru A, Pacchiarotti I, et al. Safety, tolerability, and risks associated with first- and second-generation antipsychotics: a state-of-the-art clinical review. Ther Clin Risk Manag. 2017;13:757–777.
   PubMed Web of Science ®Google Scholar
• Marder SR, Essock SM, Miller AL, et al. Physical health monitoring of patients with schizophrenia. Am J Psychiatry. 2004;161(8):1334–1349.
   PubMed Web of Science ®Google Scholar
• De Hert M, Dekker JM, Wood D, et al. Cardiovascular disease and diabetes in people with severe mental illness position statement from the european psychiatric association (EPA), supported by the european association for the study of diabetes (EASD) and the european society of cardiology (ESC). Eur Psychiatry. 2009;24(6):412–424.
   PubMed Web of Science ®Google Scholar
• Guidelines for the management of physical health conditions in adults with severe mental disorders. 2018. World Health Organization. Available from: https://apps.who.int/iris/bitstream/handle/10665/275718/9789241550383-eng.pdf?ua=1.
   Google Scholar
• Barbui C, Girlanda F, Ay E, et al. Implementation of treatment guidelines for specialist mental health care. Cochrane Database Syst Rev. 2014;(1).
   Web of Science ®Google Scholar
• McGinty EE, Baller J, Azrin ST, et al. Interventions to address medical conditions and Health-Risk behaviors among persons with serious mental illness: a comprehensive review. Schizophr Bull. 2016;42(1):96–124.
   PubMed Web of Science ®Google Scholar
• Nasjonal faglig retningslinje for individuell primaerforebygging av hjerte- og karsykdommer. 2015. The Norwegian Directorate of Health. Available from: https://helsedirektoratet.no/retningslinjer/nasjonal-faglig-retningslinje-for-individuell-primerforebygging-av-hjerte-og-karsykdommer. Accessed 01.10. 2015
   Google Scholar
• Curtis J, Newall HD, Samaras K. The heart of the matter: cardiometabolic care in youth with psychosis. Early Interv Psychiatry. 2012;6(3):347–353.
   PubMed Web of Science ®Google Scholar
• HETI Positive Cardiometabolic Health algorithm. 2015. iphYs. Available from: http://www.iphys.org.au. Accessed 1.10 2015
   Google Scholar
• Evaluation of the Implementation of Lester 2014. 2016. Royal College of Psychiatrists’ Centre for Quality Improvement. Available from: https://www.rcpsych.ac.uk/improving-care/ccqi/research-and-evaluation/research-outputs/lester-evaluation.
   Google Scholar
• Pedersen G, Hagtvet KA, Karterud S. Generalizability studies of the global assessment of Functioning-Split version. Compr Psychiatry. 2007;48(1):88–94.
   PubMed Web of Science ®Google Scholar
• Kurtze N, Rangul V, Hustvedt BE, et al. Reliability and validity of self-reported physical activity in the Nord-Trondelag health study (HUNT 2). Eur J Epidemiol. 2007;22(6):379–387.
   PubMed Web of Science ®Google Scholar
• Ringen PA, Faerden A, Antonsen B, et al. Cardiometabolic risk factors, physical activity and psychiatric status in patients in long-term psychiatric inpatient departments. Nord J Psychiatry. 2018;72(4):296–297.
   PubMed Web of Science ®Google Scholar
• Høilund H, Galea DP, Ringen PA. Improving quality of antipsychotic polypharmacy: a pilot study. Nord J Psychiatry. 2020;74(3):208–212.
   PubMed Web of Science ®Google Scholar
• Chooi YC, Ding C, Magkos F. The epidemiology of obesity. Metabolism. 2019;92:6–10.
   PubMed Web of Science ®Google Scholar
• Spahlholz J, Baer N, König H-H, et al. Obesity and discrimination - a systematic review and meta-analysis of observational studies. Obes Rev. 2016;17(1):43–55.
   PubMed Web of Science ®Google Scholar
• Schroeder SA, Morris CD. Confronting a neglected epidemic: tobacco cessation for persons with mental illnesses and substance abuse problems. Annu Rev Public Health. 2010;31(1):297–314.
   PubMedGoogle Scholar
• Crowley RA, Kirschner N, Health and Public Policy Committee of the American College of Physicians. The integration of care for mental health, substance abuse, and other behavioral health conditions into primary care: executive summary of an American college of physicians position paper. Ann Intern Med. 2015;163(4):298–299. 26121401
   PubMed Web of Science ®Google Scholar
• Somatic Health and Living Habits in Mental Disorders and/or Problems with Substances of Abuse (In Norwegian). Norwegian Directorate of Health. https://www.helsedirektoratet.no/pakkeforlop/somatisk-helse-og-levevaner-ved-psykiske-lidelser-og-eller-rusmiddelproblemer
   Google Scholar